|
LOC441089 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94780000017936E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.23460000006826E-07 |
| Normal-vs-Stage2 |
6.444700E-04 |
| Normal-vs-Stage3 |
1.709670E-02 |
| Normal-vs-Stage4 |
1.002920E-03 |
| Stage1-vs-Stage2 |
7.712000E-01 |
| Stage1-vs-Stage3 |
1.517960E-01 |
| Stage1-vs-Stage4 |
9.759000E-01 |
| Stage2-vs-Stage3 |
3.305200E-01 |
| Stage2-vs-Stage4 |
7.740800E-01 |
| Stage3-vs-Stage4 |
2.846000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.7367000018167E-08 |
| Normal-vs-AfricanAmerican |
1.361140E-04 |
| Normal-vs-Asian |
5.375400E-03 |
| Caucasian-vs-AfricanAmerican |
2.656800E-01 |
| Caucasian-vs-Asian |
7.342600E-01 |
| AfricanAmerican-vs-Asian |
4.197400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31369999825759E-08 |
| Normal-vs-Female |
4.461300E-03 |
| Male-vs-Female |
3.898500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.72659999999803E-05 |
| Normal-vs-Extreme_Weight |
2.00589999999057E-06 |
| Normal-vs-Obese |
3.164800E-04 |
| Normal-vs-Extreme_Obese |
5.99969999999228E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.311600E-01 |
| Normal_Weight-vs-Obese |
3.731000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.410200E-01 |
| Extreme_Weight-vs-Obese |
3.659400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.330800E-01 |
| Obese-vs-Extreme_Obese |
1.430040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.563500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.157620E-04 |
| Normal-vs-Age(61-80Yrs) |
1.79019999935193E-08 |
| Normal-vs-Age(81-100Yrs) |
9.70489999999602E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.643800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.023800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.070400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.819900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.034800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.825400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.17360000396039E-08 |
| Normal-VS-Type2 PRCC |
1.98719999999764E-06 |
| Normal-VS-KIRP CIMP |
6.333900E-02 |
| Normal-VS-Unclassified PRCC |
1.444500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.143800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.534600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.131400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.255800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.615000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.125600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49020000006495E-07 |
| Normal-vs-N1 |
4.477300E-03 |
| Normal-vs-N2 |
6.639700E-03 |
| N0-vs-N1 |
4.152500E-02 |
| N0-vs-N2 |
9.749600E-01 |
| N1-vs-N2 |
2.964400E-01 |
|
|
